Aparna Organics Limited - Company overview

Lantech Pharmaceuticals is shown as "Amalgamated" in MCA records.

2008-04-21 Hyderabad, Telangana Amalgamated Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹50–100 Cr
▼ -56.6%
FY 2023
PROFIT / LOSS
Loss · ₹25–50 Cr
▼ -120.4%
FY 2023
EBITDA
Loss · ₹25–50 Cr
▼ -235.7%
FY 2023
NET WORTH
Loss · ₹25–50 Cr
▼ -479.5%
FY 2023
TOTAL ASSETS
₹100–500 Cr
▼ -14.5%
FY 2023
OPEN CHARGES
6
-
PAID-UP CAPITAL
16.85 cr
AUTHORISED CAPITAL
34.00 cr
COMPANY AGE
18 Years 6 Months
since 2008-04-21
LAST FILING WITH ROC
2023-03-31
Last AGM: 2023-09-29
ACTIVE GST
2
Updated: 2024-11-28 08:21:31
TOTAL MONEY RAISED
₹25–50 Cr
SATISFIED CHARGES
10
90.57 cr

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Lantech Pharmaceuticals covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score High risk
41/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (16), financial health (10), director (95) and company-foundation signals.
  • Operating for 18+ years.
Compliance Score High risk
16/100
Statutory filings, status and regulatory flags.
  • Company status is "Amalgamated" (not Active).
  • Last balance sheet filed for Mar 2023 - filings look overdue.
Financial Health Score High risk
10/100
Profitability, leverage and liquidity from filed statements.
  • Loss-making in FY 2023.
  • Negative net worth - capital eroded by losses.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 6 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Lantech Pharmaceuticals Company identity, industry, contact, and registration details from MCA and company records.

Lantech Pharmaceuticals is shown as "Amalgamated" in MCA records. It was registered with ROC Hyderabad on 21 April 2008 as a public limited company. The registered office is at 802, Astral Heights, Road No.1 Banjara Hills, Hyderabad, Telangana. It was earlier known as Lantech Pharmaceuticals Limited.

In its MCA filings the main business is listed as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 100% of turnover.

It has six directors: Deepak Sunil Makhija, Pochana Aswin Reddy, Venu Gopal Reddy Bommireddy and 3 others. The longest-serving is Pochana Aswin Reddy, on the board since 2021; the most recent to join is Deepak Sunil Makhija, appointed in October 2022. Rakesh Reddy Chennuru is the managing director. The board changed around February 2022, when Prakash Reddy Vinta and Sashank Reddy Vinta stepped down and new directors joined. Between them, the directors also sit on the boards of 42 other companies, including Aparna Ceramic Tiles Private Limited and Aparna Ceramics Limited.

₹16.85 crore of its ₹34 crore authorised capital is paid up (about 50%). Its latest balance sheet on MCA is for the year ending 31 March 2023, and the last AGM was on 29 September 2023. All ten charges registered against it have been satisfied, so no secured loan is open.

Pharma ••••••••
  • Location 802, Astral Heights, Road No.1 Banjara Hills, Hyderabad, Telangana - 500034
  • Website lantechpharma.com
Name History
Legal NameAparna Organics Limited
CIN / LLPINU24232TG2008PLC058745
Company No.058745
ClassificationPublic Limited Indian Non-Government Company
Incorporation Date2008-04-21
Date of AGM2023-09-29
Date of Balance Sheet2023-03-31
Listing StatusUnlisted
ROC CodeRoc Hyderabad
Credit RatingB+ (Icra)
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Lantech Pharmaceuticals (6) Current board members from MCA filings, including designation and appointment details.

D
Deepak Sunil Makhija
CFO | Since 2022-10-20
P
Director | Since 2021-03-20 | DIN: 01839213
V
Director | Since 2022-02-15 | DIN: 01251924
J
Director | Since 2022-02-15 | DIN: 02107425
K
Director | Since 2022-02-18 | DIN: 01790581
R
Managing Director | Since 2021-03-20 | DIN: 00021490

Financial Performance of Lantech Pharmaceuticals Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹50–100 Cr ▼ -56.6%
P&L Loss · ₹25–50 Cr ▼ -120.4%
EBITDA Loss · ₹25–50 Cr ▼ -235.7%
Net worth Loss · ₹25–50 Cr ▼ -479.5%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Lantech Pharmaceuticals Open and satisfied charges registered against the company with MCA.

Axis Bank Limited : 47.75 cr
Others : 2.86 cr
Open Charges: 6 Satisfied Charges: 10
Open -
Satisfied 90.57 cr
LenderAmountStatus
Others
Creation Date: 28 Feb 2019
1.12 cr Closed
Others
Creation Date: 31 Aug 2018
56.00 Lakh Closed
Others
Creation Date: 30 Jun 2018
1.13 cr Closed

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products100

Companies With Common Directors Of Lantech Pharmaceuticals Other companies that share directors with this entity, based on MCA and compliance network data.

Financial Ratios of Lantech Pharmaceuticals Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

8 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Lantech Pharmaceuticals Ownership and contribution detail from filings. Full breakdown unlocks with your report.

8 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Lantech Pharmaceuticals EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Lantech Pharmaceuticals GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Lantech Pharmaceuticals Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Lantech Pharmaceuticals MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Lantech Pharmaceuticals Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lantech Pharmaceuticals Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Lantech Pharmaceuticals?
MCA does not publish an "owner" field. Lantech Pharmaceuticals is run by its directors, Deepak Sunil Makhija, Pochana Aswin Reddy, Venu Gopal Reddy Bommireddy and three others, with Rakesh Reddy Chennuru as managing director. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Lantech Pharmaceuticals?
Lantech Pharmaceuticals has six current directors: Deepak Sunil Makhija (since October 2022), Pochana Aswin Reddy (since March 2021), Venu Gopal Reddy Bommireddy (since February 2022), Jeedigunta Venkata Sai Anil Kumar (since February 2022), Kanumuri Sri Lakshmi Soma Satya Sita Rama Raju (since February 2022) and Rakesh Reddy Chennuru (since March 2021). Rakesh Reddy Chennuru is the managing director.
What is CIN of Lantech Pharmaceuticals?
The CIN of Lantech Pharmaceuticals is U24232TG2008PLC058745. Reading it left to right: U means it is not listed, 24232 is the industry code it registered under, TG is Telangana, 2008 is the year it was registered, PLC is the company type and 058745 is its registration number.
When was Lantech Pharmaceuticals incorporated?
Lantech Pharmaceuticals was incorporated on 21 April 2008 with ROC Hyderabad. That makes it about 18 years old.
What is the registered address of Lantech Pharmaceuticals?
The registered office on MCA records is 802, Astral Heights, Road No.1 Banjara Hills, Hyderabad, Telangana - 500034.
What is the current status of Lantech Pharmaceuticals?
MCA shows Lantech Pharmaceuticals as "Amalgamated". It has been merged into another company and no longer exists on its own.
What is the contact number or email for Lantech Pharmaceuticals?
You can post to its registered office at 802, Astral Heights, Road No.1 Banjara Hills, Hyderabad, Telangana - 500034 and use its website, https://lantechpharma.com.
What industry or business activity is Lantech Pharmaceuticals associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (100% of turnover).
What is paid-up capital and authorised share capital of Lantech Pharmaceuticals?
Paid-up capital is ₹16.85 crore and authorised capital is ₹34 crore, so about 50% of the authorised amount has been issued.
When did Lantech Pharmaceuticals last file accounts and hold an AGM?
The last AGM on record was on 29 September 2023, and the latest balance sheet is for the year ending 31 March 2023.
Where can I see charges and lenders for Lantech Pharmaceuticals?
No charge is open. All ten charges registered against Lantech Pharmaceuticals have been satisfied. Lenders named in the filings include Axis Bank Limited.
Have any directors left Lantech Pharmaceuticals?
Yes, 19 former directors are on record. The most recent to leave were Prakash Reddy Vinta (February 2022), Sashank Reddy Vinta (February 2022) and Vijaya Laxmi Vinta (January 2022).
Which companies share directors with Lantech Pharmaceuticals?
42 companies share directors with Lantech Pharmaceuticals. Among them are Aparna Ceramic Tiles Private Limited, Aparna Ceramics Limited, Aparna Chemicals Private Limited and 39 more.
What is the turnover or revenue of Lantech Pharmaceuticals?
Based on filed financial statements, the revenue of Lantech Pharmaceuticals for FY 2023 was in the ₹50–100 Cr range. That is down 56.6% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Lantech Pharmaceuticals?
For FY 2023, the net worth of Lantech Pharmaceuticals was negative, in the ₹25–50 Cr range.
How can I get the financial details of Lantech Pharmaceuticals?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Lantech Pharmaceuticals?
The website on record for Lantech Pharmaceuticals is https://lantechpharma.com.
Which company owns lantechpharma.com?
lantechpharma.com is the website listed for Aparna Organics Limited in its company records.
Lantech Pharmaceuticals - is it listed or unlisted?
Lantech Pharmaceuticals is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Lantech Pharmaceuticals?
Lantech Pharmaceuticals is registered with ROC Hyderabad.
What is the company classification of Lantech Pharmaceuticals?
MCA classifies Lantech Pharmaceuticals as: Public Limited Indian Non-Government Company.
Does Lantech Pharmaceuticals have GST registrations on file?
Yes, 2 active GST registrations are linked to Lantech Pharmaceuticals, usually one per state it operates in.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.